Alchemedicine Overview

  • Founded
  • 2019
Founded
  • Status
  • Private
  • Latest Deal Type
  • Early Stage VC
  • Latest Deal Amount
  • $7.17M
Latest Deal Amount
  • Investors
  • 6

Alchemedicine General Information

Description

Provider of drug discovery services intende for diseases with high unmet medical needs.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Primary Office
  • 13-2 Higashiarai, Tsukuba City
  • Ibaraki, 305-0033
  • Japan
+81 000-000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Alchemedicine Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC 16-Feb-2021 $7.17M 00.000 Completed Generating Revenue
To view Alchemedicine’s complete valuation and funding history, request access »

Alchemedicine Executive Team (1)

Name Title Board Seat Contact Info
Keigo Tanaka Chief Executive Officer, Board Member & Chairman
To view Alchemedicine’s complete executive team members history, request access »

Alchemedicine Board Members (1)

Name Representing Role Since
Keigo Tanaka Alchemedicine Chief Executive Officer, Board Member & Chairman 000 0000
To view Alchemedicine’s complete board members history, request access »

Alchemedicine Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Beyond Next Ventures Venture Capital Minority 000 0000 000000 0
Enjoyor Group Venture Capital Minority 000 0000 000000 0
Jafco Venture Capital Minority 000 0000 000000 0
Mitsubishi UFJ Capital Venture Capital Minority 000 0000 000000 0
SMBC Venture Capital Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »